bpc 157 spinal cord injury spasticity BPC-157: Tendon Repair and More The Hidden Risks of BPC‑157:

Studies suggest the compound may enhance the brain's intrinsic capacity for repair through mobilization of existing plasticity mechanisms rather than requiring exogenous cell replacement therapies

Competing Interest Statement The authors have declared no competing interest.

Frequency of Use: With consistent dosing, you might maintain elevated levels of the peptide in your body

Only 57% of participants reached the highest 2.4mg/2.4mg dose

Notably, ECs display considerably reduced levels of intercellular adhesion molecules (ICAMs) in comparison to ECs in peripheral organs, thereby imposing stringent limitations on immune cell ingress into the brain tissue [34, 35]